<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Covidien plc</title>
	<atom:link href="http://www.stockbloghub.com/tag/covidien-plc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Tue, 22 May 2012 18:53:06 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(CRDC) Cardica Reaches Second Milestone for Their Microcutter</title>
		<link>http://www.stockbloghub.com/2011/11/28/crdc-cardica-reaches-second-milestone-for-their-microcutter/87636</link>
		<comments>http://www.stockbloghub.com/2011/11/28/crdc-cardica-reaches-second-milestone-for-their-microcutter/87636#comments</comments>
		<pubDate>Mon, 28 Nov 2011 20:44:50 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Cardica Inc]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[CRDC]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=87636</guid>
		<description><![CDATA[Surgical devices maker Cardica (CRDC) has achieved the second milestone for its Microcutter product line under its distribution pact with Century Medical, a leading supplier of medical equipment in Japan. The Microcutter line of novel endoscopic stapling devices is geared for use in a variety of surgeries that require cutting and stapling. The agreement, which was inked in September 2011, provides Century Medical with exclusive rights to distribute the Microcutter products in Japan. In exchange, Century Medical agreed to provide Cardica with a loan of up to $4 million. Century&#8217;s obligation to offer the loan is contingent upon certain development milestones for the Microcutter devices. Cardica reached the first Microcutter milestone in September 2011, which has allowed it to draw down $2 million under the loan facility. With the attainment ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/11/28/crdc-cardica-reaches-second-milestone-for-their-microcutter/87636/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(CRDC) Cardica Reports Progress For Microcutter XPRESS Surgical Cutting and Stapling Device</title>
		<link>http://www.stockbloghub.com/2011/07/05/crdc-cardica-reports-progress-for-microcutter-xpress-surgical-cutting-and-stapling-device/78268</link>
		<comments>http://www.stockbloghub.com/2011/07/05/crdc-cardica-reports-progress-for-microcutter-xpress-surgical-cutting-and-stapling-device/78268#comments</comments>
		<pubDate>Tue, 05 Jul 2011 13:59:16 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Cardica Inc]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[CRDC]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=78268</guid>
		<description><![CDATA[Surgical devices maker Cardica Inc (CRDC) has reportedly completed the key internal design verification process necessary for applying the European CE Mark to its Microcutter XPRESS 30 surgical cutting and stapling device. Cardica’s internal verification process is aimed at meeting all regulatory requirements in the U.S. and Europe. Successful completion of this phase represents a key step in the commercialization of the Microcutter XPRESS 30 device in Europe. The California-based company intends to begin the first human use of the device in select European centers starting July 2011. Cardica&#8217;s Microcutter product line has been geared to offer genuine multi-fire endoscopic stapling for a number of procedures, such as thoracic, colorectal as well as general surgery. The Microcutter line-up is expected to cut and staple on a continuous basis, thereby permitting ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/07/05/crdc-cardica-reports-progress-for-microcutter-xpress-surgical-cutting-and-stapling-device/78268/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COV) Covidien&#8217;s Pipeline Device Cleared</title>
		<link>http://www.stockbloghub.com/2011/04/13/cov-covidiens-pipeline-device-cleared/71004</link>
		<comments>http://www.stockbloghub.com/2011/04/13/cov-covidiens-pipeline-device-cleared/71004#comments</comments>
		<pubDate>Wed, 13 Apr 2011 16:30:11 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=71004</guid>
		<description><![CDATA[Leading healthcare products maker Covidien plc (COV) has secured Premarket Approval (“PMA”) from the U.S. Food and Drug Administration’s (“FDA”) for its Pipeline Embolization Device for treating adults (22 years and above) with large, giant and wide-neck cerebral aneurysms (a brain vascular disorder). The approval follows the unanimous recommendation of the FDA’s advisory panel in March 2011. Covidien obtained the Pipeline Embolization Device following its $2.6 billion acquisition of endovascular devices maker ev3 Inc in July 2010. The device has CE Mark approval in Europe and has been marketed outside the U.S. since July 2009. According to Covidien, it will be available at the existing clinical sites in the U.S. shortly. Cerebral aneurysms is a condition manifested by the dilation of blood vessels in the brain due to weakness in ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/04/13/cov-covidiens-pipeline-device-cleared/71004/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(JNJ) Japan Quake Impact on Medical Technology</title>
		<link>http://www.stockbloghub.com/2011/03/28/jnj-japan-quake-impact-on-medical-technology/68708</link>
		<comments>http://www.stockbloghub.com/2011/03/28/jnj-japan-quake-impact-on-medical-technology/68708#comments</comments>
		<pubDate>Tue, 29 Mar 2011 02:41:55 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[ABT]]></category>
		<category><![CDATA[Boston Scientific Corporation]]></category>
		<category><![CDATA[BSX]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MDT]]></category>
		<category><![CDATA[Medtronic Inc]]></category>
		<category><![CDATA[St. Jude Medical Inc]]></category>
		<category><![CDATA[STJ]]></category>
		<category><![CDATA[Stryker Corporation]]></category>
		<category><![CDATA[SYK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=68708</guid>
		<description><![CDATA[Tremors triggering a quake, which struck about 250 miles north of Tokyo, followed by a colossal Tsunami, wreaked havoc on the people of the “Land of the Rising Sun” on March 11, resulting in massive carnage and destruction. The catastrophe, which is believed to have already claimed at least 10,000 lives (mostly in the northern port of Sendai) with tens of thousands still missing, has entered  the book as the largest ever in the island nation’s recorded history. Japan in Dire Straits While the human casualty is enormous, the calamity has struck a major blow to the nation’s ailing economy. The Japanese economy is forecast to slow down in 2011 (projected GDP growth of 1.3% versus 3.9% in 2010) as political instability continues to weigh on the country’s economic prospects. ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/03/28/jnj-japan-quake-impact-on-medical-technology/68708/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(BXP) Company News for January 27, 2011 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2011/01/30/bxp-company-news-for-january-27-2011-corporate-summary/65879</link>
		<comments>http://www.stockbloghub.com/2011/01/30/bxp-company-news-for-january-27-2011-corporate-summary/65879#comments</comments>
		<pubDate>Sun, 30 Jan 2011 18:15:13 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Financial]]></category>
		<category><![CDATA[REIT - Office]]></category>
		<category><![CDATA[Boston Properties Inc.]]></category>
		<category><![CDATA[BXP]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[LCC]]></category>
		<category><![CDATA[Legg Mason Inc.]]></category>
		<category><![CDATA[LM]]></category>
		<category><![CDATA[McAfee Inc.]]></category>
		<category><![CDATA[MFE]]></category>
		<category><![CDATA[Praxair Inc.]]></category>
		<category><![CDATA[PX]]></category>
		<category><![CDATA[QCOM]]></category>
		<category><![CDATA[QUALCOMM Inc]]></category>
		<category><![CDATA[SBUX]]></category>
		<category><![CDATA[Starbucks Corporation]]></category>
		<category><![CDATA[US Airways Group Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65879</guid>
		<description><![CDATA[• Qualcomm (NASDAQ:QCOM) reported Q1 EPS of $0.82, ex-items, ahead of the Zacks Consensus Estimate of $0.63 per share. Revenues for the quarter rose 25% year-over-year to $3.35 billion, above the Zacks Consensus Estimate of $3.139 billion • Starbucks (NASDAQ:SBUX) reported Q1 EPS of $0.45, above the Zacks Consensus Estimate of $0.35 per share. Revenues for the quarter rose 8% year-over-year to $2.95 billion, ahead of the Zacks Consensus Estimate of $2.716 billion • US Airways (NYSE:LCC) reported Q4 adjusted EPS of $0.17, well above the Zacks Consensus Estimate of $-0.43 per share. Revenues for the quarter rose to $2.91 billion, ahead of the Zacks Consensus Estimate of $2.858 billion • Praxiar (NYSE:PX) reported Q4 adjusted EPS of $1.25, lower than the Zacks Consensus Estimate of $1.26 per share. Revenues for the quarter rose ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/30/bxp-company-news-for-january-27-2011-corporate-summary/65879/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(LGF) Activist Investors Are Ready to Fight in 2011</title>
		<link>http://www.stockbloghub.com/2010/12/15/lgf-activist-investors-are-ready-to-fight-in-2011/62411</link>
		<comments>http://www.stockbloghub.com/2010/12/15/lgf-activist-investors-are-ready-to-fight-in-2011/62411#comments</comments>
		<pubDate>Wed, 15 Dec 2010 21:01:57 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Movie Production Theaters]]></category>
		<category><![CDATA[Services]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[ELGX]]></category>
		<category><![CDATA[Endologix Inc]]></category>
		<category><![CDATA[FO]]></category>
		<category><![CDATA[Fortune Brands Inc.]]></category>
		<category><![CDATA[GOOG]]></category>
		<category><![CDATA[Google Inc.]]></category>
		<category><![CDATA[J. C. Penney Company]]></category>
		<category><![CDATA[JCP]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[LGF]]></category>
		<category><![CDATA[Lions Gate Entertainment Corporation]]></category>
		<category><![CDATA[Massey Energy Company]]></category>
		<category><![CDATA[MEE]]></category>
		<category><![CDATA[Microsoft Corporation]]></category>
		<category><![CDATA[MSFT]]></category>
		<category><![CDATA[Occidental Petroleum Corporation]]></category>
		<category><![CDATA[OXY]]></category>
		<category><![CDATA[PFE]]></category>
		<category><![CDATA[Pfizer Inc.]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=62411</guid>
		<description><![CDATA[by Marc Lichtenfeld, Investment U’s Senior Analyst Wednesday, December 15, 2010: Issue #1408 The Chinese Zodiac says 2011 is the Year of the Rabbit. According to tradition, it’s supposed to be a period of relative calm and diplomacy, where people should opt for negotiation, rather than forcing an issue. It would be nice if that happened. But don’t expect it to occur in the stock market. I believe confrontation between executives and shareholders will take center stage in 2011, as activist investors increasingly get in the faces of underperforming management teams. But a little rumble here and there is good news for investors, as history has shown that this tactic ultimately drives the shares of those companies higher. And here’s where the scraps will occur in 2011… The Activist Investor ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/12/15/lgf-activist-investors-are-ready-to-fight-in-2011/62411/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COV) Covidien plc Quarterly Earnings Top Expectations &#8211; Profits Skyrocket</title>
		<link>http://www.stockbloghub.com/2010/11/12/cov-covidien-plc-quarterly-earnings-top-expectations-profits-skyrocket/58778</link>
		<comments>http://www.stockbloghub.com/2010/11/12/cov-covidien-plc-quarterly-earnings-top-expectations-profits-skyrocket/58778#comments</comments>
		<pubDate>Fri, 12 Nov 2010 19:46:54 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=58778</guid>
		<description><![CDATA[Ireland-based health care product maker Covidien plc (COV) reported fourth-quarter fiscal 2010 (ended September 24) adjusted earnings per share of 84 cents, exceeding the Zacks Consensus Estimate of 74 cents and the year-ago earnings of 71 cents. For fiscal 2010, adjusted earnings of $3.38 per share outshone the Zacks Consensus Estimate of $3.28 and were above the corresponding year-ago figure of $2.78. Adjusted earnings exclude one-time items such as acquisition and restructuring charges, loss on divestitures and tax-related adjustments. Net income for the quarter was $443 million (or 89 cents a share), representing a staggering eightfold annualized growth. Profits were boosted by higher sales of medical devices. Moreover, the year-ago profit (of $56 million) was hit by hefty tax expenses. For fiscal 2010, net income rocketed 80% year over year ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/12/cov-covidien-plc-quarterly-earnings-top-expectations-profits-skyrocket/58778/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(AKS) Company News for November 9, 2010 &#8211; Corporate Summary</title>
		<link>http://www.stockbloghub.com/2010/11/09/aks-company-news-for-november-9-2010-corporate-summary/58636</link>
		<comments>http://www.stockbloghub.com/2010/11/09/aks-company-news-for-november-9-2010-corporate-summary/58636#comments</comments>
		<pubDate>Wed, 10 Nov 2010 07:01:27 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Steel & Iron]]></category>
		<category><![CDATA[AK Steel Holding Corporation]]></category>
		<category><![CDATA[AKS]]></category>
		<category><![CDATA[Atlas America Inc]]></category>
		<category><![CDATA[ATLS]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[BlackRock]]></category>
		<category><![CDATA[BLK]]></category>
		<category><![CDATA[Chevron Corporation]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[CVX]]></category>
		<category><![CDATA[Goldman Sachs Group]]></category>
		<category><![CDATA[GS]]></category>
		<category><![CDATA[Marsh & McLennan Companies Inc]]></category>
		<category><![CDATA[MMC]]></category>
		<category><![CDATA[PCLN]]></category>
		<category><![CDATA[PNC]]></category>
		<category><![CDATA[PNC Financial Services Group Inc]]></category>
		<category><![CDATA[Priceline.com Inc]]></category>
		<category><![CDATA[Research In Motion Limited]]></category>
		<category><![CDATA[RIMM]]></category>
		<category><![CDATA[Symantec Corporation]]></category>
		<category><![CDATA[SYMC]]></category>
		<category><![CDATA[TYC]]></category>
		<category><![CDATA[Tyco International Limited]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=58636</guid>
		<description><![CDATA[• Chevron (NYSE:CVX) announced plans to buy Atlas Energy (NASDAQ:ATLS) for $4.3 billion, or $43.35 per share • Bank of America (NYSE:BAC) and PNC (NYSE:PNC) sold $8.3 billion of BlackRock (NYSE:BLK) shares in a secondary offering priced at $163 per share, a 3.6% discount to BlackRock&#8217;s close • Tyco International (NYSE:TYC) reported earnings of $0.74 that beat estimates of $0.66, on a 4% revenue gain to $4.5 billion, above estimates of $4.4 billion • Covidien (NYSE:COV) reported fiscal fourth quarter earnings of $0.84, a dime higher than Zacks estimates, on revenues of $2.67, up 3.1% YoY, and above Zacks estimates of $2.64 billion • Marsh &#38; McLennan (NYSE:MMC) reported third-quarter earnings of $0.30, above Zacks estimates of $0.28, on inline revenues of $2.5 billion, up 7.2% • Priceline.com (NASDAQ:PCLN) posted third quarter earnings of $5.33, above ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/11/09/aks-company-news-for-november-9-2010-corporate-summary/58636/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COV) Covidien Raises Quarterly Dividend by 11%</title>
		<link>http://www.stockbloghub.com/2010/10/12/cov-covidien-raises-quarterly-dividend-by-11/54554</link>
		<comments>http://www.stockbloghub.com/2010/10/12/cov-covidien-raises-quarterly-dividend-by-11/54554#comments</comments>
		<pubDate>Tue, 12 Oct 2010 14:32:25 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=54554</guid>
		<description><![CDATA[Covidien plc (COV), a leading healthcare products maker, recently enhanced shareholder returns by raising its quarterly dividend by 11% to 20 cents a share from 18 cents. The revised quarterly dividend is payable on Nov 8, 2010, to shareholders of record as on Oct 4, 2010. This represents the Ireland-based company’s second dividend hike over the past 12 months. Covidien’s previous dividend increase was in September 2009, when it raised the quarterly payout by 12.5% to 18 cents a share from 16 cents. Subsequently, its Board of Directors had authorized the repurchase of shares worth up to $1 billion in March 2010. The dividend increase underscores Covidien’s commitment to deliver incremental returns to investors leveraging a solid free cash flow and strong earnings power. The company continues to maintain a ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/10/12/cov-covidien-raises-quarterly-dividend-by-11/54554/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COV) Covidien Beats The Street by a Nickel</title>
		<link>http://www.stockbloghub.com/2010/07/30/cov-covidien-beats-the-street-by-a-nickel/45401</link>
		<comments>http://www.stockbloghub.com/2010/07/30/cov-covidien-beats-the-street-by-a-nickel/45401#comments</comments>
		<pubDate>Fri, 30 Jul 2010 21:24:20 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[BCR]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[Cr Bard Inc]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=45401</guid>
		<description><![CDATA[Ireland-based healthcare product maker Covidien plc (COV) reported third-quarter fiscal 2010 results with adjusted (excluding one-time items such as restructuring charges and tax-related adjustments) earnings per share of 85 cents beating the Zacks Consensus Estimate of 80 cents and exceeding the year-ago quarter earnings of 74 cents. Net income from continued operation sailed 29% year-over-year to $352 million (or 70 cents a share), favored by higher medical devices sales and lower research and development expenses. Revenues Net sales edged up 2% year-over-year to $2.56 billion, but missed the Zacks Consensus Estimate of $2.62 billion as incremental revenues from medical devices were marred by the decline in the pharmaceuticals division. Segment Analysis Medical Devices revenues grew 6% year-over-year to $1.54 billion on the back of double-digit revenue expansions across Oximetry and ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/30/cov-covidien-beats-the-street-by-a-nickel/45401/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(JNJ) Johnson &amp; Johnson Announces They Will Aquire Micrus Endovascular</title>
		<link>http://www.stockbloghub.com/2010/07/25/jnj-johnson-johnson-announces-they-will-aquire-micrus-endovascular/43222</link>
		<comments>http://www.stockbloghub.com/2010/07/25/jnj-johnson-johnson-announces-they-will-aquire-micrus-endovascular/43222#comments</comments>
		<pubDate>Sun, 25 Jul 2010 17:56:47 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Drug Manufacturers - Major]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[ev3 Inc]]></category>
		<category><![CDATA[EVVV]]></category>
		<category><![CDATA[JNJ]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[MEND]]></category>
		<category><![CDATA[Micrus Endovascular Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=43222</guid>
		<description><![CDATA[Johnson &#38; Johnson (JNJ) recently announced plans to acquire medical devices maker Micrus Endovascular Corp. (MEND), based in San Jose, California, for $480 million in cash or $23.40 per share for each of Micrus’ 20.5 million shares outstanding. The offer price represents a 5.5% premium over the closing price of Micrus’ shares on July 9. The boards of directors of both the companies have approved the deal, which now awaits shareholder and regulatory approval. The deal, which is scheduled to close in the second half of 2010, is expected to be breakeven to slightly dilutive to Johnson &#38; Johnson’s 2010 earnings per share. Johnson &#38; Johnson expects 2010 earnings in the range of $4.80 to $4.90 per share on total revenues of $63.5 billion to $64.0 billion. At the time ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/07/25/jnj-johnson-johnson-announces-they-will-aquire-micrus-endovascular/43222/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(MASI) Masimo Corporation in Expansion Mode</title>
		<link>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870</link>
		<comments>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870#comments</comments>
		<pubDate>Wed, 30 Dec 2009 01:04:32 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Medical Appliances & Equipment]]></category>
		<category><![CDATA[BDX]]></category>
		<category><![CDATA[Becton Dickinson Company]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>
		<category><![CDATA[MASI]]></category>
		<category><![CDATA[Masimo Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=23870</guid>
		<description><![CDATA[Masimo Corp. (MASI) recently announced the expansion of its corporate campus in Irvine, California with the addition of an adjacent 32,000 sq. ft. building. This is the company&#8217;s third building on its corporate campus. Masimo stated that the new building is expected to accommodate more than 200 employees. The expansion of Masimo’s corporate headquarters will further strengthen its engineering, sales and administrative functions in 2010. These are required to accommodate the increasing demand for its breakthrough medical technologies Incorporatedluding the expansion of its Masimo Rainbow SET Pulse CO-Oximetry and new Acoustic Monitoring business. The current year alone has seen more than 150 hospitals throughout the world adapt the company’s advanced pulse oximetry technology. As a reminder, earlier this month, Masimo’s new customer, Brookdale University Hospital and Medical Center in Brooklyn, New ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/12/29/masi-masimo-corporation-in-expansion-mode/23870/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(COV) Covidien Limited &#8211; Earnings Surprise Streak Broken</title>
		<link>http://www.stockbloghub.com/2009/10/16/cov-covidien-limited-earnings-surprise-streak-broken/17836</link>
		<comments>http://www.stockbloghub.com/2009/10/16/cov-covidien-limited-earnings-surprise-streak-broken/17836#comments</comments>
		<pubDate>Sat, 17 Oct 2009 00:20:47 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[COV]]></category>
		<category><![CDATA[Covidien plc]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=17836</guid>
		<description><![CDATA[Covidien Limited (COV) has surprised on estimates 3 out of the last 4 quarters. The company also recently raised its dividend. Covidien is trading at 13.6x forward earnings. Company Description Covidien manufactures medical devices, medical supplies and imaging solutions. It has pioneered the use of contrast media, electrosurgery, surgical stapling and laparoscopic instrumentation. It has 16 manufacturing facilities in 16 countries and sales representatives in 50 countries worldwide. 45% of its sales are outside the United States. Covidien Raised Its Dividend On Sep 25, Covidien joined the rare club of companies that actually raised its distribution payment in the last 12 months. The company announced a 12.5% increase to 18 cents from 16 cents per share payable on Nov 6 to shareholders of record as of Oct 6. The current ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/10/16/cov-covidien-limited-earnings-surprise-streak-broken/17836/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

